22-Sep-2010
Fast Company
In some countries, up to 90% of children with AIDS are dependent on India’s cheap, generic drugs.
20-Sep-2010
DNP+
We request organizations and individuals across the world to join Delhi Network of Positive People in a sign on letter to issue a appeal to the Indian government to ’not sign on’ to any IP provisions in the FTA negotiations.
15-Sep-2010
UNITAID
A new study from UNITAID warns that free trade agreements India is currently negotiating may close the tap on affordable medicines for AIDS patients.
4-Sep-2010
If commerce ministry officials have their way in negotiations, all future free trade agreements (FTA) will include a clause protecting India’s interests against third-party agreements, which include FTA partner nations.
30-Aug-2010
The Indian government’s doublespeak on generic medicines has the stakeholders in a tizzy.
19-Aug-2010
India has said that it will not compromise on issues related to health and people’s right to medicine in the bilateral trade and investment agreement being negotiated with the European Union.
3-Aug-2010
IPS
There are already reports that India and the European Union will have a free-trade agreement ready by the end of August, causing more nervous chatter here in India
22-Jul-2010
PIJIP
It appears that the EU has dropped its demands for patent
extensions and may have made data exclusivity subject to compulsory licensing in the EU-India FTA.
21-Jul-2010
AFP
Le stand de la Commission européenne à la Conférence internationale sur le sida à Vienne a été "saisi" symboliquement mercredi par des militants pour protester contre des saisies dans l’UE de médicaments génériques destinés à des pays en développement.
8-Jun-2010
A key provision in the draft of the India-European Union (EU) free trade agreement (FTA) may have implications on the affordability of medicines, while also hurting the negotiations between the two trading blocs.
28-Apr-2010
IP Watch
Negotiations on the EU-India free trade agreement continue tomorrow in Brussels amid warnings from NGOs from India and Europe about possible negative consequences for the public health of poor citizens in India
27-Apr-2010
Indian pharmaceutical firms and the network of public health groups have separately urged the government to keep patent-related issues out of the ongoing talks for the proposed India-EU free trade agreement.
26-Apr-2010
It took two years of secret suffering and gut-wrenching diarrhea to make Lumkile Sizila face the fact that he had HIV.
21-Apr-2010
Civil society and public health groups from India, Brazil and several other countries today vehemently objected to the proposed India-European Union Free Trade Agreement (FTA).
24-Mar-2010
The Delhi Network of Positive People (DNP+) is calling on the EU Trade Commissioner to come clean on the demands and pressures being placed by the European Union on the Government of India to accept TRIPS-plus measures that will have a severe, adverse impact on access to safe, effective and affordable medicines in India and across the developing world.
23-Mar-2010
Commerce minister Anand Sharma said on Monday that a proposed free-trade agreement (FTA) with the European Union (EU) would not hurt the generic drugs industry. The minister also said India would attract the same amount of foreign direct investment as last year.
15-Mar-2010
With the looming threat of these supply lines being disrupted by TRIPS+ provisions that are likely to be demanded of the Indian Government by FTA negotiators from the European Union and Japan we request that the Indian Government stand firm on their position of refusing all TRIPS+ provision that maybe included in any final agreement.
15-Mar-2010
Reuters
Poor people in India and other developing countries may lose access to affordable generic drugs as part of free-trade negotiations between India and the European Union, a medical advocacy group said on Friday.
4-Feb-2010
Pharma Times
The eighth round of the FTA talks which took place in Mumbai last week have been strongly criticised in India for their secrecy and lack of consultation with the national parliament and state governments.
